Ambuan, Feldora D.

HRN: 21-65-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2022
CEFUROXIME 1.5GM (VIAL)
07/31/2022
08/07/2022
IV
1.5gm
Q8
WBC = 30.4; T/c UTI
08/01/2022
CEFUROXIME 500MG (TAB)
08/01/2022
08/08/2022
ORAL
500mg
BID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: